MX2010002352A - Piperazinil pirazinas y piridinas substituidas como antagonistas del receptor 5-ht7. - Google Patents

Piperazinil pirazinas y piridinas substituidas como antagonistas del receptor 5-ht7.

Info

Publication number
MX2010002352A
MX2010002352A MX2010002352A MX2010002352A MX2010002352A MX 2010002352 A MX2010002352 A MX 2010002352A MX 2010002352 A MX2010002352 A MX 2010002352A MX 2010002352 A MX2010002352 A MX 2010002352A MX 2010002352 A MX2010002352 A MX 2010002352A
Authority
MX
Mexico
Prior art keywords
pyridines
receptor antagonists
optionally substituted
substituted piperazinyl
pyrazines
Prior art date
Application number
MX2010002352A
Other languages
English (en)
Spanish (es)
Inventor
Michael Philip Cohen
Michael Wade Tidwell
Sandra Ann Filla
Sarah Lynn Hellman
Sean Patrick Hollinshead
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2010002352A publication Critical patent/MX2010002352A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2010002352A 2007-08-28 2008-08-19 Piperazinil pirazinas y piridinas substituidas como antagonistas del receptor 5-ht7. MX2010002352A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96834407P 2007-08-28 2007-08-28
US4875208P 2008-04-29 2008-04-29
PCT/US2008/073543 WO2009029439A1 (en) 2007-08-28 2008-08-19 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
MX2010002352A true MX2010002352A (es) 2010-08-04

Family

ID=39873874

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002352A MX2010002352A (es) 2007-08-28 2008-08-19 Piperazinil pirazinas y piridinas substituidas como antagonistas del receptor 5-ht7.

Country Status (21)

Country Link
US (1) US8048884B2 (OSRAM)
EP (1) EP2188268B1 (OSRAM)
JP (1) JP5290293B2 (OSRAM)
KR (1) KR101148616B1 (OSRAM)
CN (1) CN101790522B (OSRAM)
AR (1) AR068111A1 (OSRAM)
AT (1) ATE520673T1 (OSRAM)
AU (1) AU2008293715B2 (OSRAM)
BR (1) BRPI0816468A2 (OSRAM)
CA (1) CA2694911C (OSRAM)
CY (1) CY1111848T1 (OSRAM)
DK (1) DK2188268T3 (OSRAM)
EA (1) EA017809B1 (OSRAM)
HR (1) HRP20110624T1 (OSRAM)
MX (1) MX2010002352A (OSRAM)
PE (1) PE20090629A1 (OSRAM)
PL (1) PL2188268T3 (OSRAM)
PT (1) PT2188268E (OSRAM)
SI (1) SI2188268T1 (OSRAM)
TW (1) TW200914020A (OSRAM)
WO (1) WO2009029439A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118473B (fi) 2006-02-17 2007-11-30 Outotec Oyj Menetelmä kuparin talteenottamiseksi kuparisulfidimalmista
KR101161070B1 (ko) * 2007-10-12 2012-07-13 일라이 릴리 앤드 캄파니 5-ht7 수용체 길항제
EP2558458B1 (de) 2010-04-16 2017-09-06 Bayer Intellectual Property GmbH Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
EP2766353B1 (en) 2011-10-11 2015-06-17 UCB Pharma, S.A. 2-oxo-piperidinyl derivatives
FR2995605B1 (fr) 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.
US10351535B2 (en) * 2013-12-20 2019-07-16 Esteve Pharmaceuticals, S.A. Piperazine derivatives having multimodal activity against pain
EP3589626B1 (en) 2017-03-03 2024-06-12 National Taiwan University 8-phenyl-isoquinolines and pharmaceutical composition thereof used in the treatment of irritable bowel syndrome
KR102014335B1 (ko) * 2017-12-01 2019-08-26 한국과학기술연구원 5-ht7 수용체의 조절제로 작용하는 아릴피라졸릴피페라진 또는 아릴피라졸릴다이아제페인의 유도체 및 이를 포함하는 중추신경계 질환 치료 또는 예방용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047559A2 (en) * 1999-02-10 2000-08-17 Eli Lilly And Company 5-ht1f agonists
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
MXPA05008137A (es) * 2003-01-31 2005-09-30 Pfizer Prod Inc Antagonistas y agonistas de 5ht7.
US7153858B2 (en) * 2003-01-31 2006-12-26 Epix Delaware, Inc. Arylpiperazinyl compounds

Also Published As

Publication number Publication date
ATE520673T1 (de) 2011-09-15
JP5290293B2 (ja) 2013-09-18
EA201070321A1 (ru) 2010-08-30
BRPI0816468A2 (pt) 2015-03-24
AU2008293715B2 (en) 2013-09-19
KR20100038117A (ko) 2010-04-12
KR101148616B1 (ko) 2012-05-21
PT2188268E (pt) 2011-10-03
CN101790522A (zh) 2010-07-28
PE20090629A1 (es) 2009-05-16
CA2694911A1 (en) 2009-03-05
EA017809B1 (ru) 2013-03-29
CA2694911C (en) 2013-05-07
DK2188268T3 (da) 2011-10-03
HRP20110624T1 (hr) 2011-09-30
AU2008293715A1 (en) 2009-03-05
US8048884B2 (en) 2011-11-01
CN101790522B (zh) 2012-06-27
WO2009029439A1 (en) 2009-03-05
TW200914020A (en) 2009-04-01
EP2188268A1 (en) 2010-05-26
US20100075976A1 (en) 2010-03-25
CY1111848T1 (el) 2015-10-07
PL2188268T3 (pl) 2011-12-30
EP2188268B1 (en) 2011-08-17
JP2010537994A (ja) 2010-12-09
SI2188268T1 (sl) 2011-11-30
AR068111A1 (es) 2009-11-04

Similar Documents

Publication Publication Date Title
MX2010002352A (es) Piperazinil pirazinas y piridinas substituidas como antagonistas del receptor 5-ht7.
NO20074368L (no) Syklopentapyridin- og tetrahydroquinolinderivater
NO20083582L (no) Pyridin-2-karboksamide derivater
ATE524466T1 (de) 3-azabicycloä3.3.0üoktanverbindungen
DE602006007556D1 (de) Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
MY148322A (en) Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
ATE483707T1 (de) 2-cyclopropylthiazolderivate
ATE397601T1 (de) Pyridin-4-yl-ethynylimidazole und -pyrazole als antagonisten des mglu5-rezeptors
NO20074287L (no) Pyrazin-2-karboksamidderivater som mGluR5 antagonister
AR067528A1 (es) Eteres heterociclicos sustituidos y su uso en trastornos del snc
ATE422198T1 (de) Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
GEP20115201B (en) Cinnamoyl-piperazine derivatives and their use as par- i antagonists
HRP20120762T1 (hr) Tetrasupstituirani piridazini kao inhibitori hedgehog puta
MX2012006962A (es) Inhibidores de la esfingosina quinasa.
ATE478054T1 (de) Benzimidazolderivate
MY183039A (en) Pyridin-2-yl derivatives as immunomodulating agents
MX2010004498A (es) Derivados de ciclohexenoamida y su uso como antagonistas de trpv1.
NZ552137A (en) New 4-benzylidene-piperidin derivatives
MX356478B (es) 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il]1h-pirazol-3-il}-et il)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8.
MXPA05010646A (es) Pirazoles sustituidos.
TW200726764A (en) N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
SI2201002T1 (sl) Antagonisti 5-ht7 receptorja
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
DE602007004327D1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors

Legal Events

Date Code Title Description
FG Grant or registration